Tonix Pharmaceuticals Holding Corp: Regulation Fd Disclosure, On March 24, 2025, The Company Announced That The Fda Will Not Require An Advisory Committee Meeting To Discuss The Nda For Tnx102 Sl For The Management Of Fibromyalgia, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Tonix Pharmaceuticals Holding Corp.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***